Search details
1.
Impact of germline HLA genotypes on clinical outcomes in patients with urothelial cancer treated with pembrolizumab.
Cancer Sci
; 113(12): 4059-4069, 2022 Dec.
Article
in English
| MEDLINE | ID: mdl-35848083
2.
Impact of histological variants on outcomes in patients with urothelial carcinoma treated with pembrolizumab: a propensity score matching analysis.
BJU Int
; 130(2): 226-234, 2022 08.
Article
in English
| MEDLINE | ID: mdl-34110696
3.
Risk stratification for the prognosis of patients with chemoresistant urothelial cancer treated with pembrolizumab.
Cancer Sci
; 112(2): 760-773, 2021 Feb.
Article
in English
| MEDLINE | ID: mdl-33283385
4.
Impact of prior intravesical bacillus Calmette-Guerin therapy on the effectiveness of pembrolizumab for patients with metastatic urothelial carcinoma.
Urol Oncol
; 40(3): 107.e1-107.e9, 2022 03.
Article
in English
| MEDLINE | ID: mdl-34454824
5.
[Granulocyte colony stimulating factor-producing spindle cell renal cell carcinoma successfully treated by chemotherapy consisting of gemcitabine and doxorubicin].
Hinyokika Kiyo
; 57(7): 385-9, 2011 Jul.
Article
in Japanese
| MEDLINE | ID: mdl-21832875
Results
1 -
5
de 5
1
Next >
>>